Vontobel Holding’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$364K Buy
+12,611
New +$340K ﹤0.01% 1175
2025
Q4
Sell
-11,713
Closed -$382K 1486
2025
Q3
$382K Buy
11,713
+941
+9% +$34.7K ﹤0.01% 1034
2025
Q2
$382K Buy
+10,772
New +$349K ﹤0.01% 975
2024
Q4
Sell
-11,267
Closed -$549K 1141
2024
Q3
$549K Sell
11,267
-345
-3% -$18.4K ﹤0.01% 761
2024
Q2
$514K Sell
11,612
-1,252
-10% -$57.8K ﹤0.01% 754
2024
Q1
$722K Sell
12,864
-253
-2% -$15.3K 0.01% 672
2023
Q4
$789K Buy
+13,117
New +$831K 0.01% 662
2022
Q2
Sell
-27,258
Closed -$1.01M 1078
2022
Q1
$1.01M Sell
27,258
-1,185
-4% -$46.8K 0.01% 621
2021
Q4
$1.42M Sell
28,443
-5,704
-17% -$289K 0.01% 543
2021
Q3
$1.73M Sell
34,147
-4,962
-13% -$206K 0.02% 474
2021
Q2
$1.6M Buy
+39,109
New +$1.33M 0.01% 496

Other funds holding LEGN

Vontobel Holding's LEGN Position: Q2 2026 in Review

Vontobel Holding opened a new position in Legend Biotech (LEGN) in Q2 2026: 12,611 shares worth $364K. The stake represents ﹤0.01% of the portfolio and ranks #1175 among its holdings. This is a return to the name: Vontobel Holding previously reported a position in LEGN as recently as Q3 2025.

Vontobel Holding first reported a position in LEGN in Q2 2021 and has held it in 11 quarters since. The position peaked at $1.73M in Q3 2021. 79 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Vontobel Holding held 12,611 shares of Legend Biotech worth $364K as of Q2 2026.
  • Legend Biotech was a new Vontobel Holding position in Q2 2026.
  • Legend Biotech made up ﹤0.01% of Vontobel Holding's portfolio in Q2 2026, its #1175 holding.
  • Vontobel Holding first reported a position in Legend Biotech in Q2 2021 and has held it in 11 quarters since.
  • Vontobel Holding's Legend Biotech position peaked at $1.73M in Q3 2021.
  • 79 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.